CA-PHELPS-BRAND
Phelps Brand today announced Canada’s youngest World Champion swimmer Penny Oleksiak is joining the team as an official global ambassador. As part of the Phelps Team, Oleksiak will train and compete utilizing the industry-leading range of products from training equipment to performance swim suits, including the FINA-approved Matrix Technical suit, which is available now to consumers worldwide at www.michaelphelps.com .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201008005297/en/
Oleksiak, a World Champion swimmer and Olympic-record holder, has been tapped as the face of the Matrix campaign, the Phelps Brand’s first new product launch in 2020. As part of the Phelps Team, Oleksiak (CAN) will help advance the brand globally alongside the growing roster of elite athletes including World Champion and American-record holder Chase Kalisz (USA), two-time Olympian Georgia Davies (UK), French-record holder David Aubry (FRA) and Olympian Luca Pizzini (IT).
“I’m a big fan of Penny and what she’s been able to accomplish in the pool. I’m thrilled she is joining the Phelps Team as the first female global ambassador,” said Phelps. “Penny is a tremendous athlete who shares my passion for the sport and has already provided a lot of great insights for the Phelps Brand. Her personality, talent and confidence are huge assets for the entire swimming community.”
A four-time Olympic medalist and six-time World Championship medalist, Oleksiak is a force on Team Canada. As Canada’s youngest Olympic gold medalist, she holds the nation’s record for most Olympic medals at a single summer games. In her short career she has become known for her exciting come from behind victories, winning four Olympic and six World medals; and currently holds the Olympic Record for the 100 Freestyle.
“I am so excited to be part of the Phelps Team,” said Oleksiak. “I have looked up to Michael my entire career and now have the chance to learn from and work alongside him to bring an incredible experience and line of products to the swimming community. It really is a dream come true for me.”
The Phelps Brand, which originally launched as MP Brand in 2015, continues to develop technologically advanced racing and training suits for competitive swimmers under the direction of Michael Phelps and Hall of Fame coach Bob Bowman.
The first product to launch under the Phelps Brand is the Matrix Tech Suit, a top-of-the-line FINA-approved competitive tech suit created with propriety Exo-Core technology. The Matrix features both adaptive compression material to reduce muscle vibration and drag while ensuring maximum flexibility and freedom of movement. In addition, the Matrix includes a sustaining tape system for improved body position by utilizing front and back axis tape and cross-coordinating to improve length and position.
“Penny is a tremendous athlete and her unique experiences and insights will play a key role in helping inform the competitive swim product innovation in the Phelps Brand today,” said Andrew Gritzbaugh, General Manager of North America for Aqua Lung, the parent company of Phelps Brand and Aqua Sphere. “We’re very excited to welcome her to the team and look forward to supporting her in her future endeavors.”
To purchase Phelps Brand products go to www.michaelphelps.com .
About PHELPS BRAND
The Phelps Brand offers best-in-class, innovative swim products that are inclusive and accessible to a broad range of swimmers across the competitive swimming lifecycle. Combining Aqua Sphere’s global product design expertise and distribution with Michael Phelps’ and Coach Bob Bowman’s experiences at the highest levels of swim performance, the Phelps Brand features technical swim products leveraging proprietary technologies and performance enhancing designs. For more information, visit www.michaelphelps.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20201008005297/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 04:37:00 CET | Press release
The Challenge: Deepfakes undermine both the accuracy and fairness of AI face detection due to variations in human features.The Technology: Ant International’s AI model uses a novel ‘Mixture of Experts’-based Adversarial Debiasing approach to achieve superior fairness and accuracy across diverse demographics.The Impact: This advancement strengthens payment security, offering robust protection against deepfake fraud and enhancing eKYC compliance globally. Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the Nati
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
